+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biotechnology Entrepreneurship. Leading, Managing and Commercializing Innovative Technologies. Edition No. 2

  • Book
  • May 2020
  • Elsevier Science and Technology
  • ID: 4768564

This second edition of Biotechnology Entrepreneurship: Leading, Managing, and Commercializing Innovative Technologies is an authoritative, easy-to-read guide covering biotechnology entrepreneurship and the process of commercializing innovative biotechnology products. This best practice resource is for professional training programs, individuals starting a biotech venture, and for managers and experienced practitioners leading biotech enterprises. It is a valuable resource for those working at any level in the biotech industry, and for professionals who support and provide essential resources and services to the biotech industry. This practical, "how-to” book is written by seasoned veterans experienced in each of the operational functions essential for starting, managing, and leading a successful biotech company.

Biotechnology Entrepreneurship explains the biotech business components and underlying strategies, interspersed with practical lessons from successful biotech entrepreneurs, educators, and experienced practitioners. These veteran contributors share their insights on how to be successful in this challenging but exciting industry. Subjects range from technology licensing and translating an idea into a viable business, forming your legal company entity, securing angel and venture capital, navigating product development, FDA regulatory approval, and biomanufacturing.

This book is a user-friendly guide to decision-making and overall strategy written as a hands-on management tool for leaders and managers of these dynamic biotechnology ventures. If you are contemplating starting a biotech company, are a manager at any level, a seasoned veteran, or service provider in the biotech industry, this book is a "must read.”

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

SECTION 1: UNDERSTANDING BIOTECHNOLOGY ENTREPRENEURSHIP 1. What is Biotechnology Entrepreneurship? 2. A Biotechnology Entrepreneur's Story Advice to Entrepreneurs: 2 Tributes to Henri A. Termeer 3. A Biotechnology Entrepreneur's Story: From Start-up to International Contract Development and Manufacturing Organization 4. Characteristics of Successful Biotechnology Leaders

SECTION 2: OVERVIEW OF THE BIOTECHNOLOGY INDUSTRY 5. Unleashing the Promise of Biotechnology to Help Heal, Fuel and Feed the World 6. Five Essential Elements for Growing Biotechnology Clusters

SECTION 3: THE HUMAN CAPITAL COMPONENT 7. Building, Managing and Motivating Great Teams 8. Building Human Relationship Networks 9. Mentorship: Why You Need a Team of Mentors to be Successful

SECTION 4: THE INNOVATIVE TECHNOLOGY COMPONENT 10. Understanding Biotechnology Product Sectors 11. Technology Opportunities: Evaluating the Idea 12. Understanding Biotechnology Business Models and Managing Risk 13. Directing Your Technology Toward a Market Problem: What You Need to Know Before Applying the Business Model Canvas

SECTION 5: THE EMERGING BIOTECHNOLOGY ENTERPRISE 14. Company Formation, Ownership Structure and Securities Issues 15. Licensing the Technology: Biotechnology Commercialization Strategies Using University & Federal Labs 16. Intellectual Property Protection Strategies for Biotechnology Innovations

SECTION 6: THE FINANICAL CAPITAL COMPONENT 17. Sources of Capital and Investor Motivations 18. How Investors Really Make Decisions: What Entrepreneurs Need to Know When Raising Money 19. Securing Angel Capital and Understanding How Angel Networks Operate 20. Understanding and Securing Venture Capital: an Entrepreneur's Perspective 21. Financial Ramifications of Funding a Biotechnology Venture: What you Need to Know about Valuation and Term Sheets 22. Your Business Plan and Presentation: Articulating Your Journey to Commercialization 23. Investor Presentations: What Do You Need in an Investor Pitch Deck

SECTION 7: BIOTECHNOLOGY PRODUCT DEVELOPMENT 24. Therapeutic Drug Development and Human Clinical Trials 25. Integrating Diagnostic Applications into the Drug Development Workflow: Applications for Companion Diagnostics 26. The Development and Commercialization of Medical Devices 27. Commercialization and Applications of Agricultural Biotechnology 28. Artificial Intelligence: Emerging Applications in Biotechnology and Pharma 29. Regulatory Implications and Market Approval Considerations for Artificial Intelligence Products 30. Regulatory Approval and Compliances for Biotechnology Products 31. The Biomanufacturing of Biotechnology Products

SECTION 8: BIOTECHNOLOGY MARKET DEVELOPMENT 32. Biotechnology Products and Their Customers: Developing a Successful Market Strategy 33. Biotechnology Product Coverage, Coding, and Reimbursement Strategies 34. Getting the Word Out: Public Relations Strategies to Support Biotechnology Business Goals

SECTION 9: THE LATTER-STAGE BIOTECHNOLOGY COMPANY 35. Company Growth Stages and the Value of Corporate Culture 36. Biotechnology Business Development: The Art of a Deal 37. Biotech-Pharma Collaboration A Strategic Tool: Case Study of Centocor 38. The Emergence and Transformation of China in Biotechnology: Partnering with China 39. Ethical Considerations for Biotechnology Entrepreneurs (suggested change to "Leaders") 40. Diverse Career Opportunities in the Biotechnology and Life Sciences Industry 41. Common Biotech Entrepreneur Mistakes and How to Avoid them 42. Summary


Craig Shimasaki BioSource Consulting Group, Oklahoma City, OK, USA. Dr. Craig Shimasaki is a scientist, businessperson, and serial entrepreneur, with over 35 years of biotechnology industry experience starting his career at Genentech in South San Francisco, California. He cofounded nine life science companies and participated in taking five public in the US and Canadian stock exchanges. He is an inventor on multiple biotech patents and is currently the CEO of Moleculera Labs and BioSource Consulting. He teaches biotechnology entrepreneurship at the University of Oklahoma, United States, as an Entrepreneur-in-Residence at the Price School of Business. His passion is to train and equip entrepreneurial leaders to successfully translate basic discoveries into needed products and services for unmet medical needs.